/ Recent Posts /
Willow Bark: More Than Pain Relief
Willow bark has been used for thousands of years to treat pain and inflammation in both China and Europe. It’s so effective, in fact, that ...
Breakthrough Results with MCP for Prostate Cancer
Prostate cancer is the second most common cause of cancer-related death in men. While there have been several diagnostic and treatment advancements in recent years, ...
Turmeric Works as Well as Drugs for Treating Indigestion
Turmeric, the spice that gives curry its yellow color, has been as an herbal remedy for nearly 4,000 years. Its active component, curcumin, is an ...
Study Finds Most Saw Palmetto Supplements Fall Short
A study in the Journal of Urology Open Plus found that only 7 out of 28 saw palmetto supplements met the potency standards to address ...
Peppermint Essential Oil Eases Pain After Heart Surgery
A new study published in BMJ Supportive & Palliative Care finds that an aromatherapeutic treatment with peppermint essential oil can help ease post-surgery pain.
Ginger for Pain Relief: 5 Supporting Studies
One of the most widely known and respected herbal remedies, ginger has been a go-to for pain relief for thousands of years.
White Willow Bark for Pain: 2 Supporting Studies
Extracts of the bark of trees from the genus Salix, more commonly known as willow, have been used to treat pain and inflammation for thousands ...
Boswellia for Pain: 3 Supporting Studies
Steeped in tradition, the time-tested herb Boswellia serrata, aka Frankincense, has shown promise for non-addictive pain relief in numerous studies.
Curcumin May Hold the Key for Colon Cancer Treatment
A study published in the journal Nature shows that curcumin, an active compound in the curry spice turmeric, can suppress the metastasis of colorectal cancer ...
When antihypertensive drugs lose efficacy, rule out interactions with dietary supplements
Anticipating possible interactions between drugs and dietary supplements is a challenging area of integrative practice. When we think about interactions, we tend to envision risks ...